TAIMedImg DeepMets
Overview
TAIMedImg DeepMets is an AI-aided brain metastasis supportive detection system, specifically DeepMets®-Plus, designed to assist trained medical professionals. It provides initial object contours on axial T1-weighted contrast-enhanced (T1WI+C) brain magnetic resonance (MR) images to accelerate the workflow for radiation therapy treatment planning. The software is intended for patients with known (imaging diagnosed) brain metastases (BM) and is specifically for lesions with a diameter of ≥ 10 mm. Utilizing deep learning neural networks, DeepMets generates contours and annotations for diagnosed brain metastases and converts them into standard DICOM-RTSTRUCT files, ensuring compatibility with radiotherapy treatment planning systems. This innovation significantly reduces the time physicians require to review medical images from approximately 10 minutes to just 30 seconds and can shorten the patient’s overall medical service process from two weeks to half a day. Furthermore, the platform incorporates federated learning and validation mechanisms to protect patient privacy while enabling collaborative AI model training across multiple institutions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-aided brain metastasis detection and contouring on MRI
- Automated segmentation for Gross Tumor Volume (GTV) contours
- Accelerates workflow for radiation therapy treatment planning
- Generates reports in PDF and DICOM-RTSTRUCT (RTSS) format
- Federated Learning for privacy-preserving AI model training across institutions
- High sensitivity (85% for 4mm tumors, 97% for 10mm tumors)
- Reduces image review time from 10 minutes to 30 seconds
- Supports adult patients with known brain metastases (lesions u2265 10mm)
- Explainable, Traceable, Verifiable, and Auditable AI
- AI Agents with generative capabilities for report drafting and clinical decision assistance
Use Cases
- Assisting radiologists and clinicians in detecting brain metastases on MRI
- Accelerating radiation therapy treatment planning
- Improving workflow efficiency in radiosurgery procedures
- Generating diagnostic reports and assisting with clinical decisions
- Prognosis prediction and treatment tracking
- Collaborative development and validation of cross-center AI models while safeguarding privacy
What Physicians Need to Know
TAIMedImg DeepMets is an assistive AI tool designed to streamline radiation therapy planning for brain metastases. Physicians must always thoroughly review and finalize the AI-generated contours on T1WI+C brain MR images, especially for lesions u226510mm. This tool can significantly reduce diagnostic turnaround time and enhance workflow efficiency, allowing for faster treatment decisions. Remember, the physician retains ultimate responsibility for diagnosis and treatment.
DeepMets outputs in DICOM RTSS format, ensuring compatibility with standard image visualization software and treatment planning systems. Its federated learning architecture allows for secure, on-premise data processing and collaborative model improvement across institutions without sharing raw patient data, aligning with strict privacy regulations like GDPR. Deployment via Microsoft Azure further enhances its accessibility and integration potential within existing healthcare IT infrastructures.
Details
| Category | Oncology AI |
| Pricing | Contact for pricing. |
| Deployment | Globally via Microsoft Azure; Federated platform supporting on-premise data processing with shared models. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated TAIMedImg DeepMets has received TFDA (Taiwan FDA) approval as a Software as a Medical Device (SaMD) since September 2022. It also obtained Philippine FDA certification in November 2024. The device has a US FDA 510(k) Premarket Notification (K250427) with a submission date of May 28, 2025, indicating its intent to assist trained medical professionals by providing initial object contours on axial T1-weighted contrast-enhanced brain MR images to accelerate workflow for radiation therapy treatment planning for known brain metastases with lesions ≥ 10 mm. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Oncology, Radiology |
What the Web Says
TAIMedImg DeepMets is an AI-powered software designed to assist medical professionals in contouring images and automating the segmentation of Gross Tumor Volume (GTV) for brain metastases. It is intended as an adjunctive tool to complement, rather than replace, manual contouring processes, with physicians retaining ultimate responsibility for diagnosis and treatment decisions. The software has undergone performance testing and demonstrated safety and effectiveness, performing comparably to predicate devices.
Overall: PositiveStrengths
- Automated segmentation of GTV for brain metastases.
- Adjunctive tool to assist medical professionals.
- Demonstrated safety and effectiveness in performance testing.
- Performs comparably to predicate devices.
- Aids in streamlining the contouring process.
Limitations
- Not intended to replace manual contouring; requires thorough review by a medical professional.
- Physician retains ultimate responsibility for diagnosis and treatment.
- Only valid for DICOM images of adult patients.
- Exclusions for patients with prior craniotomy, non-BM brain tumors, or excessive motion artifacts.
Based on reviews from: accessdata.fda.gov
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate TAIMedImg DeepMets
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for TAIMedImg DeepMets.
No videos found. Search YouTube directly
